key: cord-1008159-w7hv7u09 authors: Adegbite, Bayode R; Edoa, Jean R; Ndzebe Ndoumba, Wilfrid F; Dimessa Mbadinga, Lia B; Mombo-Ngoma, Ghyslain; Jacob, Shevin T; Rylance, Jamie; Hänscheid, Prof. Thomas; Adegnika, Prof. Ayola A; Grobusch, Prof. Martin P title: A comparison of different scores for diagnosis and mortality prediction of adults with sepsis in Low-and-Middle-Income Countries: a systematic review and meta-analysis date: 2021-10-30 journal: EClinicalMedicine DOI: 10.1016/j.eclinm.2021.101184 sha: 154081ec7c6fce2332f4c2043162d447f9ae22dd doc_id: 1008159 cord_uid: w7hv7u09 BACKGROUND: Clinical scores for sepsis have been primarily developed for, and applied in High-Income Countries. This systematic review and meta-analysis examined the performance of the quick Sequential Organ Failure Assessment (qSOFA), Systemic Inflammatory Response Syndrome (SIRS), Modified Early Warning Score (MEWS), and Universal Vital Assessment (UVA) scores for diagnosis and prediction of mortality in patients with suspected infection in Low-and-Middle-Income Countries. METHODS: PubMed, Science Direct, Web of Science, and the Cochrane Central Register of Controlled Trials databases were searched until May 18, 2021. Studies reporting the performance of at least one of the above-mentioned scores for predicting mortality in patients of 15 years of age and older with suspected infection or sepsis were eligible. The Quality Assessment of Diagnostic Accuracy Studies tool was used for risk-of-bias assessment. PRISMA guidelines were followed (PROSPERO registration: CRD42020153906). The bivariate random-effects regression model was used to pool the individual sensitivities, specificities and areas-under-the-curve (AUC). FINDINGS: Twenty-four articles (of 5669 identified) with 27,237 patients were eligible for inclusion. qSOFA pooled sensitivity was 0·70 (95% confidence interval [CI] 0·60–0·78), specificity 0·73 (95% CI 0·67–0·79), and AUC 0·77 (95% CI 0·72–0·82). SIRS pooled sensitivity, specificity and AUC were 0·88 (95% CI 0·79 -0·93), 0·34 (95% CI 0·25–0·44), and 0·69 (95% CI 0·50–0·83), respectively. MEWS pooled sensitivity, specificity and AUC were 0·70 (95% CI 0·57 -0·81), 0·61 (95% CI 0·42–0·77), and 0·72 (95% CI 0·64–0·77), respectively. UVA pooled sensitivity, specificity and AUC were 0·49 (95% CI 0·33 -0·65), 0·91(95% CI 0·84–0·96), and 0·76 (95% CI 0·44–0·93), respectively. Significant heterogeneity was observed in the pooled analysis. INTERPRETATION: Individual score performances ranged from poor to acceptable. Future studies should combine selected or modified elements of different scores. FUNDING: Partially funded by the UK National Institute for Health Research (NIHR) (17/63/42). Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection; it is responsible for twenty percent of all-cause global mortality, the majority of which occurs in low-and-middleincome countries (LMICs). 1, 2 Sepsis is a syndrome that can manifest in affected patients as a broad constellation of symptoms and signs caused by the interplay of pathogens and host factors. To address the challenge of sepsis diagnosis, multiple sepsis diagnostic and mortality prediction models or scores have been developed. The availability of sophisticated laboratory investigation tools and early warning scores are important instruments to improve diagnosis and management of sepsis in high-income countries (HICs), but applying those to LMIC settings is complex. The first early warning score published in 1997 was designed to enable detection of changes in illness severity using aberrations in vital signs. In 2001, the Modified Early Warning Score (MEWS) was published. It was created by assigning weighted scores to five physiological parameters (systolic blood pressure, pulse rate, respiratory rate, temperature and level of consciousness) based on severity of the abnormality. 3 Though not specific for sepsis, MEWS is intended to support medical staff in anticipating patients' clinical deterioration. Sepsis definitions have been modified significantly between 1991 and 2016. 4 The current definition describes sepsis as organ dysfunction caused by dysregulated host response to infection. For clinical operationalisation, organ dysfunction is represented by an increase in the Sequential (sepsis-related) Organ Failure Assessment (SOFA) score of two points or more. 5 The preceding sepsis screening tool utilised the systemic inflammatory response syndrome (SIRS) criteria but was suggested to be abandoned by the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) task force due to concerns about its lack of specificity in identifying patients with severe disease resulting in potential over-treatment of patients with milder disease. 5 SOFA, however, requires laboratory values which may not be readily available outside of a highly resourced intensive care unit (ICU). Accordingly, the quick SOFA (qSOFA) score was proposed as a screening tool to identify patients at high risk of poor outcome. 5 MEWS, SIRS and qSOFA were mainly developed in HICs. LMICs share a high burden of many infectious diseases, for which sepsis is the common final pathway. Studies validating these scores in LMICs are limited, with performances differing from one study to another. 6−9 Recently, the Universal Vital Assessment (UVA) score was developed, using multiple cohorts of patients from sub-Saharan African countries with suspected infection, demonstrating good performance in predicting in-hospital mortality. 10 The UVA score included points for systolic blood pressure, Glasgow Evidence before this study There was no earlier systematic review reporting the performance comparison of the four scores, and previous systematic reviews and meta-analyses included predominantly studies from high income countries (HICs). Variation in clinical presentation, aetiology of sepsis and limited access to intensive care unit between HICs and low-and-middle-income countries (LMICs) settings may contribute to differences between the performance of the scores. The performance of four available scores, Sequential Organ Failure Assessment (qSOFA), Systemic Inflammatory Response Syndrome (SIRS), Modified Early Warning score (MEWS), and Universal Vital Assessment (UVA) in the diagnosis of sepsis and in-patient mortality prediction in patients with suspected infection in LMICs was systematically reviewed for the first time. Currently used scores yield variable performance, ranging from poor to acceptable, in predicting mortality or sepsis diagnosis when applied to adult patients hospitalised with infectious diseases in LMIC settings. The sensitivity of qSOFA might be higher in LMICs than that reported from HICs. However, further validation studies are needed. Our analysis suggests a two-step approach to better predict worst outcome in patients with suspected infection in LMICs. The SIRS score has best sensitivity; it could assist clinicians in making the first triage, followed by the qSOFA, MEWS, or UVA scores to inform decisions about the appropriate level of care. Coma Scale score, temperature, oxygen saturation, respiratory and heart rates, and humon immunodeficiency virus (HIV) serostatus. 10 Its performance has been assessed by now in several studies in Africa. 7, 11 In LMICs, there are limited healthcare resources and ICU facilities. As a consequence, severe and critically-ill patients cannot always be admitted to an ICU. Therefore, an applicable triage score that is easily applied by frontline clinicians is paramount in order to prioritise care. Previous systematic reviews assessed the performance of the qSOFA, SIRS, and MEWS scores, but did not focus on LMICs. 12 Compared with SIRS, qSOFA showed better specificity for predicting mortality but lower sensitivity for identifying patients with sepsis in patients with suspected infection. 6, 13 It is well-known that setting and study population might influence the accuracy of screening and diagnostic testing. 14 This systematic review and meta-analysis assessed the performance of four available scores (qSOFA, SIRS, MEWS, UVA) in the diagnosis of sepsis and in-patient mortality prediction in adult non-pregnant and non-surgical patients with suspected infections in LMICs. This systematic review and meta-analysis followed the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement extension for Diagnostic Test Accuracy (DTA). 15 An electronic search of the published literature was conducted on November 04, 2019 and updated on May 18, 2021 in PubMed, Science Direct, Web of Science, and the Cochrane Central Register of Controlled Trials. We used the following search terms: 'qsofa', 'sofa', 'sirs,' 'UVA', 'MEWS', 'sequential organ failure assessment', 'systemic inflammatory response syndrome', 'Universal Vital Assessment', 'Early Warning Score', 'sepsis', 'infections'. In addition, we used a filter suggested by the Cochrane Collaboration based on the World Bank list of low-income, lower-middle-income or upper-middle-income countries. 16 Articles resulting from these searches and relevant references cited in those articles were reviewed. The full search strategy used is reported in Supplementary File S1. Studies which recruited patients 15 years of age and older with suspected infection or sepsis were eligible for inclusion using the following criteria: (1) full-length reports published in peer-reviewed journals; (2) observational studies or clinical trials of adult (>15 years old) patients; (3) studies that describe data about sepsis assessment using at least one of the four scores; and (4) studies that report the relationship between the sepsis screening criteria and at least one of the following outcomes: sensitivity or specificity for diagnosis of sepsis (organ dysfunction, SOFA ≥2), deaths that occurred in hospital, or any post-hospital discharge outcomes. According to the published definitions, qSOFA was considered positive when at least two variables met fulfilment criteria'; SIRS when at least two criteria were met; MEWS when at least five score criteria were met; and UVA when at least five score criteria were met. The details of each score are provided in Supplementary File S2. We excluded studies which were not performed in LMICs, studies which did not report sensitivity, specificity, or data to calculate the score performance characteristics, and studies limited to specific patient populations (such as COVID-19 or pneumonia patients). Two investigators (WNN & LBD) independently screened studies for eligibility; disagreement was resolved by consensus. If WNN and LBD did not agree after discussion, a third investigator (BRA) was consulted. The study protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO; CRD42020153906; available from: https://www.crd. york.ac.uk/prospero/display_record.php? ID=CRD42020153906) and amended once. The following data were extracted from the original studies: first author; year of publication; country of origin; study design; sample size; mortality rate; patient selection criteria; score evaluated, objectives and outcomes. In case of missing information, we contacted the respective corresponding authors. BRA and JRE independently extracted potentially relevant studies and reviewed each study according to the pre-defined eligibility criteria. The primary outcome was overall mortality (in-hospital or 28/30 days mortality). The secondary outcome was diagnosis of sepsis (acute organ dysfunction). The Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 tool was used to assess the risk of bias in diagnostic test accuracy, 17 as recommended by the Cochrane Collaboration. Consensus on the risk of bias was sought by two reviewers (BRA and WNN). A detailed quality assessment is provided in Supplementary File S3; articles rejected are listed in Supplementary File 4. Statistical analysis was conducted using RevMan5.4 (Nordic Cochrane Center, Copenhagen, Denmark) 18 and RStudio 4.0.2 (250 Northern Ave, Boston, USA). 19 We generated true positives, false negatives, false positives, and true negatives based on sensitivity, specificity, and 95% confidence intervals (CIs) of each study using RevMan5.4. We used the packages 'meta' 20 and 'mada' (version 0.5.10) 21 in CRAN-R to produce the meta-analysis forest and funnel plots. Between studies, statistical heterogeneity was assessed using the I 2 statistic and Cochran's Q test; I 2 values of more than 50% indicated Articles www.thelancet.com Vol xx Month xx, 2021 a significant level of heterogeneity. Funnel plots were used to assess publication bias (Supplementary File S5). Pooled sensitivity and specificity were calculated using a bivariate random-effects regression model. The summary receiver operator curves were constructed, and the area under the curve (AUC) was used to appreciate the discriminatory performance of each score. No ethical clearance was required for this systematic review and meta-analysis. The supporting funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author, Martin P. Grobusch accessed the dataset, and the decision to submit for publication was jointly taken by all authors. In total, 8526 published articles were initially identified (3741 articles from PUBMED, 136 articles from Science Direct, 2093 articles from the Cochrane Library, and 2556 on Web of Science). After removing duplicate articles, 5669 potentially eligible articles were screened. Of these articles, 5495 were excluded on the basis of title and abstract. A total of 174 articles underwent full-text review. One hundred fifty-five articles were excluded for the reasons presented in Figure 1 . Finally, a total of 24 articles met our inclusion criteria for the systematic review and meta-analysis. All studies were published between 2013 and 2021. Characteristics of the studies included are presented in Table 1 . The number of patients per study ranged from 64 to 6218, and the overall mortality rate in each study ranged from 3¢8 % to 61¢0%. Across studies, the two most-frequently reported conditions were respiratory tract infections and malaria. Twenty-three studies reported qSOFA (26,460 participants) score performance; twelve (15,401 participants) reported SIRS performance, nine reported MEWS (13,063 participants), and four reported UVA (6841 participants). Six studies compared the accuracy of qSOFA and SIRS, five studies compared qSOFA and MEWS, and three studies compared qSOFA and UVA criteria. One study compared all four scores. Two studies reported the performance of qSOFA in the diagnosis of sepsis. All studies included were observational. More than half were prospective. The studies were well designed, the quality assessment demonstrated a low risk of bias. The detailed QUADAS-2 assessment is presented in Supplementary File S3. For mortatlity, the pooled sensitivity of qSOFA across all included studies was 0¢70 (95% CI 0¢60 −0¢78); the pooled specificity was 0¢73 (95% CI 0¢67 −0¢79) (Figure 2A) ; and the pooled AUC was 0¢77 (95% CI 0¢72−0¢82). SIRS pooled sensitivity and specificity for predicting mortality were 0¢88 (95% CI 0¢79 -0¢93) and 0¢34 (95% CI 0¢25−0¢44) ( Figure 2B ), respectively; the pooled AUC was 0¢69 (95% CI 0¢50 −0¢83). MEWS pooled sensitivity and specificity were 0¢70 (95% CI 0¢57 -0¢81) and 0¢61 (95% CI 0¢42−0¢77) Fig. 2C) , respectively; the pooled AUC was 0¢72 (95% CI 0¢64−0¢77). UVA sensitivity and specificity were 0¢49 (95% CI 0¢33 -0¢65) and 0¢91 (95% CI 0¢84 −0¢96) (Figure 2 D) , respectively; the pooled AUC 0¢76 (95% CI 0¢44−0¢93). In the subgroup analysis assessing the performance of qSOFA in ICU vs outside of ICU, the sensitivity and the AUC of qSOFA in predicting mortality was better in studies assessing its performance in ICU compared with non-ICU areas ( In those studies simultaneously reporting the accuracy of a positive qSOFA score and positive SIRS criteria for predicting mortality, the qSOFA score was more specific but less sensitive than SIRS; qSOFA, MEWS, and UVA performed similarly (Table 2) . Three studies that reported the prognostic performance of positive qSOFA scores in predicting acute organ dysfunction; the pooled sensitivity, specificity, and AUC were 0¢43 (95% CI 0¢30 -0¢57), 0¢85 (95% CI 0¢78 -0¢90), and 0¢76 (95% CI 0¢5 -0¢86), respectively. The pooled performance of SIRS in the diagnosis of acute organ dysfunction was as follows: sensitivity 0¢87 (95% CI 0¢58 -0¢97); specificity 0¢30 (95% CI 0¢11 -0¢59); and AUC 0¢62 (95% CI 0¢35 -0¢85). In this systematic review and meta-analysis, the prognostic capability of qSOFA, SIRS, MEWS, and UVA for predicting mortality and organ dysfunction in adult patients with suspected infection or sepsis in LMICs was evaluated. The performance of qSOFA outside of ICU in our systematic review is lower to what was reported in the original study assessing the performance of qSOFA (0¢72 (95% CI 0¢68-0¢75) vs 81(95% CI 0¢80−0¢82)). 22 It is also lower than the performance (0¢78 (95% CI, 0¢72−0¢84)) reported in 2018 in a systematic review including both HICs and LMICs. 23 The sensitivity of qSOFA in this systematic review, however, is higher than that determined by the systematic review which included studies from HICs only (0¢76; 95% CI 0¢59−0¢88 vs 0¢58; 95% CI 0¢47−0¢67). 24 The difference in the performance of qSOFA in HICs as compared to LMICs could be due to patient characteristics and differences in the respective infectious disease burden, as well as variation in healthcare resources, and the degree to which definitive diagnostics are available (such as CT or MRI scans, bronchoscopy etc.). Furthermore, the mechanisms that lead to life-threatening acute organ dysfunction from infections such as malaria, tuberculosis, and HIV which are more prevalent in LMICs can differ from those of classic bacterial sepsis. 25, 26 Some studies suggest the combination of qSOFA with biomarkers, such as C-reative protein and procalcitonin, to increase its sensitivity. 27 The Sepsis 3.0 task force designed qSOFA criteria to replace SIRS to identify patients with suspected infection who would require early diagnosis and treatment. However, our meta-analysis demonstrates that qSOFA had a poor sensitivity for predicting mortality as compared with SIRS. To that end, SIRS should not be abandoned as it could provide utility in a staged approach with qSOFA, whereby SIRS is used as a primary screening tool to identify patients requiring a high level of care, and qSOFA is applied subsequently for predicting mortality; an approach which to the best of our knowledge has not yet been investigated systematically. The comparison of MEWS and qSOFA performance (AUC) in predicting mortality showed that they performed similarly (0¢73 (95% CI 0¢63-0¢79) vs 0¢69 (95% CI 0¢65-0¢74)). However, the sensitivity of MEWS is higher than that of qSOFA. When a high sensitivity trigger is used, it is more likely that the patient will be identified sooner. However, if a 'sepsis bundle' is administered to patients who ultimately do not have sepsis, there is a risk of over-treatment, and there are substantial concerns about excessive fluid administration and antibiotic use 28 In LMIC settings, patients with HIV have an increased risk for developing sepsis. 25 In our meta-analysis, the UVA score had the highest specificity (0¢92, 95% CI 0¢82; 0¢96). The UVA was reported as an appropriate score to assess in-hospital mortality risk in adults, and derived exclusively from data from six sub-Saharan African countries; 29 further prospective validation would be helpful. Pathogen spectrum and clinical presentation of sepsis may be different between LMICs and high-income settings. Due to the lack of human resources and ICU facilities in LMICs, there is a need to develop reliable triage scores to determine who requires the highest available level of care. Our meta-analysis demonstrates that there is no single top-performing score. Future studies should investigate the performance of amalgamated (i.e. combining the best of different scores) and combined scores (staged using sensitivity score, followed by the more specific) in various countries. Our review has several limitations. First, there was considerable heterogeneity between the studies included. Second, the definition of suspected infection varied among studies; and due to the retrospective design of many studies, these differences would have introduced selection bias. Third, we were unable to directly compare the four scores because there was one study simultaneously reporting the performance of these scores. In conclusion, there is not a single score which ultimately identifies, with accuracy, patients with suspected infections or sepsis at high risk of death or clinical condition deterioration. Amongst the scores readily at hand, SIRS could be applied to first screening to identify those patients requiring high-level care, followed by qSOFA, MEWS, or UVA scores, based both on published performance indicators and subject to local availability of data collection tools, for mortality prediction. There is a need to perform further studies to validate the UVA score. In general, future studies should investigate the performance of combined or sequential use of scores, or their amalgamation, i.e. optimalisation by combining selected or modified elements of different scores. This altogether could help to further improve patient triage in resource-limited environments and serve as a standard for mortality risk in future studies. MPG and BRA conceptualised the study. BRA, MPG and AAA determined the methodological approach. BRA,JRE, WNN and LBN primarily investigated the data and conducted the formal data analysis. MPG and AAA provided and organised study resources. BRA, MPG, GMN curated the data. BRA wrote the original draft, with input from MPG. BRA, TH, JR, STJ, and MPG, together with all co-authors, did the editing and the writing of the final manuscript version. MPG supervised the project. MPG and AAA administered the project. All authors contributed to the writing of the final manuscript version, and have read and agreed to the published version of the manuscript. Data will be made available upon request made to the corresponding author. The analysis code used in this study is available online. None of the author has any competing interests to declare. This research was partially funded by the National Institute for Health Research (NIHR) (17/63/42) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK government. Global, regional, and national sepsis incidence and mortality, 1990−2017: analysis for the Global Burden of Disease Study Standardized measurement of the Modified Early Warning Score results in enhanced implementation of a Rapid Response System: a quasi-experimental study Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) Head-to-head comparison of qSOFA and SIRS criteria in predicting the mortality of infected patients in the emergency department: a meta-analysis A Prospective Comparison of Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome Criteria, Universal Vital Assessment, and Modified Early Warning Score to Predict Mortality in Patients with Suspected Infection in Gabon Mortality outcomes based on ED qSOFA score and HIV status in a developing low income country Monsomboon A. The utility of the rapid emergency medicine score (REMS) compared with SIRS, qSOFA and NEWS for Predicting in-hospital Mortality among Patients with suspicion of Sepsis in an emergency department Derivation and validation of a universal vital assessment (UVA) score: a tool for predicting mortality in adult hospitalised patients in sub-Saharan Africa Predicting mortality in adults with suspected infection in a Rwandan hospital: an evaluation of the adapted MEWS, qSOFA and UVA scores Sepsis and Septic Shock in Low-and Middle-Income Countries A Comparison of the Quick-SOFA and Systemic Inflammatory Response Syndrome Criteria for the Diagnosis of Sepsis and Prediction of Mortality Variation of a test's sensitivity and specificity with disease prevalence Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement Embase (Ovid), and CENTRAL (Cochrane Library) to help identify studies relevant to LMIC. /lmic-filters QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies The Cochrane Collaboration R:A language and environment for statistical computing How to perform a meta-analysis with R: a practical tutorial mada: Meta-Analysis of Diagnostic Accuracy Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) Performance of the quick Sequential (sepsis-related) Organ Failure Assessment score as a prognostic tool in infected patients outside the intensive care unit: a systematic review and meta-analysis Quick Sequential Organ Failure Assessment as a prognostic factor for infected patients outside the intensive care unit: a systematic review and meta-analysis Aetiology and outcomes of sepsis in adults in sub-Saharan Africa: a systematic review and meta-analysis Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low-and Middle-Income Countries Combining procalcitonin with the qSOFA and sepsis mortality prediction Scoring systems for the characterization of sepsis and associated outcomes Derivation and validation of a universal vital assessment (UVA) score: a tool for predicting mortality in adult hospitalised patients in sub-Saharan Africa A Prospective Comparison of Quick Sequential Organ Failure Assessment, Systemic Inflammatory Response Syndrome Criteria, Universal Vital Assessment, and Modified Early Warning Score to Predict Mortality in Patients with Suspected Infection in Gabon Prognostic value of quickSOFA as a predictor of 28-day mortality among febrile adult patients presenting to emergency departments in Dar es Salaam The Prevalence and Outcomes of Sepsis in Adult Patients in Two Hospitals in Malawi Usefulness of qSOFA and SIRS scores for detection of incipient sepsis in general ward patients: A prospective cohort study Accuracy of qSOFA for the diagnosis of sepsis-3: a secondary analysis of a population-based cohort study Comparing the effectiveness of three scoring systems in predicting adult patient outcomes in the emergency department Prognostic value of Modified Early Warning Score generated in a Chinese emergency department: a prospective cohort study Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low-and Middle-Income Countries Application of the qSOFA score to predict mortality in patients with suspected infection in a resource-limited setting in Malawi Comparison of qSOFA and SOFA score for predicting mortality in severe sepsis and septic shock patients in the emergency department of a low middle income country Evaluation of the modified MEDS, MEWS score and Charlson comorbidity index in patients with community acquired sepsis in the emergency department Comparison of the performance of SOFA, qSOFA and SIRS for predicting mortality and organ failure among sepsis patients admitted to the intensive care unit in a middle-income country Prognostic accuracy of the quick Sequential Organ Failure Assessment (qSOFA)-lactate criteria for mortality in adults with suspected bacterial infection in the emergency department of a hospital with limited resources Comparison the accuracy of early warning scores with qSOFA and SIRS for predicting sepsis in the emergency department Diagnostic and Prognostic Utility Compared Among Different Sepsis Scoring Systems in Adult Patients With Sepsis in Thailand: A Prospective Cohort Study The comparative ability of commonly used disease severity scores to predict death or a requirement for ICU care in patients hospitalised with possible sepsis in Yangon, Myanmar Comparison of SOFA Score, SIRS, qSOFA, and qSOFA + L Criteria in the Diagnosis and Prognosis of Sepsis Utility of quick sepsis-related organ failure assessment (qSOFA) score to predict outcomes in out-of-ICU patients with suspected infections Supplementary material associated with this article can be found in the online version at doi:10.1016/j. eclinm.2021.101184.